Purpose: To determine the relationship between hepatic proton density fat fraction (PDFF) and R2* in vivo. Materials and Methods: In this Health Insurance Portability and Accountability Act (HIPAA)-compliant, Institutional Review Board (IRB)-approved, cross-sectional study, we conducted a secondary analysis of 3T magnetic resonance imaging (MRI) exams performed as part of prospective research studies in children in whom conditions associated with iron overload were excluded clinically. Each exam included low-flip-angle, multiecho magnitude (-M) and complex (-C) based chemical-shift-encoded MRI techniques with spectral modeling of fat to generate hepatic PDFF and R2* parametric maps. For each technique and each patient, regions of interest were placed on the maps in each of the nine Couinaud segments, and composite whole-liver PDFF and R2* values were calculated. Pearson's correlation coefficients between PDFF and R2* were computed for each MRI technique. Correlations were compared using Steiger's test. Results: In all, 184 children (123 boys, 61 girls) were included in this analysis. PDFF estimated by MRI-M and MRI-C ranged from 1.1-35.4% (9.44 6 8.76) and 2.1-38.1% (10.1 6 8.7), respectively. R2* estimated by MRI-M and MRI-C ranged from 32.6-78.7 s 21 (48.4 6 9.8) and 27.2-71.5 s 21 (42.2 6 8.6), respectively. There were strong and significant correlations between hepatic PDFF and R2* values estimated by MRI-M (r 5 0.874; P < 0.0001) and MRI-C (r 5 0.853; P < 0.0001). The correlation coefficients (0.874 vs. 0.853) were not significantly different (P 5 0.15). Conclusion: Hepatic PDFF and R2* are strongly correlated with each other in vivo. This relationship was observed using two different MRI techniques. Level of Evidence: 2 Technical Efficacy: Stage 1
P roton density fat fraction (PDFF) and R2* measurements are increasingly investigated as noninvasive quantitative imaging biomarkers of hepatic steatosis [1] [2] [3] [4] [5] [6] and hepatic iron content, 7, 8 respectively. To estimate PDFF and R2*, advanced multiecho chemical-shift-encoded magnetic resonance imaging (MRI) techniques using either magnitude-based data (MRI-M) or complex-based data (MRI-C) have been developed. [9] [10] [11] To address potential confounders, these techniques simultaneously estimate PDFF and R2* by acquiring multiple echoes to correct for R2* (1=T Ã 2 ) signal decay, with a low flip angle to minimize T 1 weighting, and applying spectral modeling to account for the multipeak nature of fat. [12] [13] [14] [15] [16] These techniques have been proposed for simultaneous assessment of fat and iron. [16] [17] [18] [19] Both MRI-M and MRI-C fit PDFF and R2* simultaneously but independently, as the signal model implicitly assumes that PDFF and R2* reflect distinct and unrelated physiological processes. Kuhn et al 14 showed that when multipeak spectral modeling is applied, liver R2* measurements made by MRI-C are independent of the steatosis grade in adults with mixed chronic liver disease. However, a recent study by Bashir et al reported a direct correlation between PDFF and R2* measured using MRI-C in human livers in vivo. 9 Since the only two published studies in the literature provide discordant results and since both studies included only adults and measured R2* using MRI-C only, there is a need to further investigate the relationship between PDFF and R2*. The purpose of this study was to determine the relationship between PDFF and R2* estimated by MRI-M and MRI-C in prospective cohort studies of pediatric nonalcoholic fatty liver disease (NAFLD). 20, 21 We selected children because they rarely have excess hepatic iron 22, 23 and are an ideal population to determine the relationship between PDFF and R2* unconfounded by iron content. A secondary purpose of the study was to evaluate the agreement between MRI-M and MRI-C for estimating R2* values in human subjects, and to validate the high agreement between these techniques reported in prior studies for estimating PDFF.
24,25

Materials and Methods
Research Design and Subjects
This was a single-site, cross-sectional, secondary analysis of data collected in pediatric participants enrolled in prospective cohort studies at our institution, who underwent a research liver MRI exam including both MRI-M and MRI-C at our imaging center between August 2008 and December 2015. We included children who were at risk for NAFLD due to an elevated body mass index; defined as having a BMI percentile !85th percentile for age and sex. 26 We also included children with a history of NAFLD. The diagnosis of NAFLD was not made as part of this study, but was based on a combination of clinical history, laboratory studies, and, if available, liver histology as previously described. 27 Two children (a 17-year-old boy and a 10-year-old girl) with prior blood transfusions were excluded, as the transfusions could cause iron overload.
No child had any liver disease(s) other than NAFLD. The final study population comprised 184 children with characteristics summarized in Table 1 . The study was approved by an Institutional Review Board and was compliant with the Health Insurance Portability and Accountability Act. Children under 18 years signed informed assent, with written informed consent provided by their parent(s)/ guardian(s); 18-19-year-olds signed informed consent. Demographic and anthropometric information was collected for enrolled children.
MRI
Children were asked to fast for 4 hours before the MRI exam and were scanned at 3T (Signa EXCITE HDxt scanner, GE Medical Systems, Waukesha, WI) in a supine position with an eightchannel torso phased-array coil centered over the liver. A dielectric pad was placed between the coil and the abdomen. Each MR exam included chemical-shift-encoded MRI-M and MRI-C techniques as illustrated in Fig. 1 and described below. Acquisition parameters are summarized in Table 2 . Both techniques assumed exponential R2* signal decay and applied the same multipeak fat spectral model derived from human liver triglyceride composition. 28 31, 32 Due to the fat-water signal dominance ambiguity intrinsic to magnitude fitting, water was assumed to be the dominant signal and the PDFF dynamic range was 0-50%. No correction was made for phase errors, as these are considered negligible with magnitude fitting.
MRI-M Acquisition and Reconstruction
MRI-C Acquisition and Reconstruction
A 3D multiecho SPGR sequence was acquired with full liver coverage in a single 20-second breath-hold with 2D parallel imaging and an effective net acceleration factor of 2.2 using Auto-calibrating Reconstruction for Cartesian imaging. To minimize T 1 weighting, a low flip angle (38) was used with 6.9 msec TR. 33, 34 Six echoes were obtained per TR at TEs, as these are appropriate for fat-water separation using complex fitting. Images were reconstructed by the scanner computer using an investigational version of a complex-data based water-fat separation technique known as Iterative
Decomposition of water and fat with Echo Asymmetry and Leastsquares estimation (IDEAL). 35 As described in Yu et al, 16 this algorithm combines the strengths of both complex and magnitude reconstruction techniques in a hybrid approach 16 that corrects for the phase errors 36 that may confound pure complex fitting. The algorithm generates water and fat images, as well as PDFF and R2* maps. Since this technique is capable of distinguishing signals from fat and water, the PDFF dynamic range is 0-100%.
MRI Analysis
MRI-M AND MRI-C ESTIMATION OF PDFF AND R2*. Source images and the PDFF and R2* parametric maps were transferred offline for analysis (Osirix Foundation, Geneva, Switzerland) by image analysts (each with more than 6 months of training) blinded to clinical data. One circular region of interest (ROI) with a 1-cm radius was manually placed in each of the nine Couinaud liver segments on the fifth-echo image of the MRI-M source images, avoiding major vessels, bile ducts, liver edges, and artifacts. The fifth-echo image was used to guide ROI placement because it consistently provided adequate anatomic delineation for this purpose. The nine ROIs from these images were then copied onto the MRI-C water images, with adjustment if needed to avoid major vessels, bile ducts, liver edges, and artifacts. The nine ROIs were then copied to the corresponding locations in the PDFF and R2* maps for both techniques (see Fig. 1 ) without additional adjustment. For each subject, composite PDFF and R2* values for each technique were calculated by averaging the individual mean values from the nine ROIs.
Statistical Analysis
All statistical analyses were performed by a staff biostatistician under the supervision of a faculty statistician, both with over 20 years of experience, using R statistical computing software (R v. 3.1.2 (2014-10-31) R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria). Cohort characteristics were summarized descriptively (see Table 2 ). Pearson's correlation between PDFF and R2* was calculated for MRI-M and MRI-C and compared using Steiger's test for dependent correlations. Agreement between MRI-M and MRI-C for estimating PDFF and R2* was assessed by Bland-Altman analysis. Bias (the mean difference between MRI-M and MRI-C) and its P-value, standard deviation (SD) of the MRI-M and MRI-C differences, and limits of agreement (LOA) were computed as part of the analysis. All statistical hypothesis testing was performed using a significance level of 0.05.
Results
Cohort Characteristics
In all, 184 children (123 boys, 61 girls) met inclusion criteria for the study. PDFF estimated by MRI-M and MRI-C ranged from 1.1-35.4% (9.44 6 8.76) and 2.1-38.1% Correlation Between PDFF and R2* Figure 2 illustrates parametric maps in three representative pediatric participants spanning a spectrum of PDFF and R2* values (low, medium, and high). As illustrated in Fig. 2 and shown graphically in Fig. 3 , PDFF correlated with R2* for both techniques (r 5 0.874, P < 0.0001 for MRI-M; r 5 0.853, P < 0.0001 for MRI-C). The correlation coefficients (0.874 vs. 0.853) were not significantly different (P 5 0.15). Figure 4 shows Bland-Altman plots of intertechnique agreement for estimating PDFF (Fig. 4a ) and R2* (Fig. 4b) . MRI-M estimated PDFF was significantly (P < 0.0001) lower than MRI-C estimated PDFF with a mean bias of -0. 
Agreement Between MRI-M and MRI-C
Discussion
We demonstrated a direct correlation between PDFF and R2*, as measured by both MRI-M and MRI-C, in children spanning a wide range of hepatic PDFF and who were unlikely to have excess hepatic iron accumulation. The PDFF-R2* relationship was observed using two different PDFF-R2* quantification approaches (MRI-M and MRI-C), indicating it is not a technique-dependent spurious finding. We also demonstrated close intertechnique agreement in PDFF and R2*, although MRI-M compared to MRI-C slightly underestimated the PDFF and overestimated the R2*.
The direct correlation between PDFF and R2* in children is consistent with a recent study in adults by Bashir et al 9 that reported moderate correlation using three different analytical algorithms for MRI-C data at 3T Our results and those of Bashir et al 9 differ from those of Kuhn et al, 14 who reported a nonsignificant correlation between R2* estimated by confounder-corrected MRI-C and histologic steatosis grade. Since histologic steatosis grade is a 4-point ordinal score with broad brackets of fat content (<5%, 5-33%, 34-66%, >67%), while R2* is a continuous measurement, the reliance on histologic steatosis grade as the measure of liver fat in the Kuhn et al study may have reduced statistical power for detecting a significant correlation. Also, Kuhn et al included adult patients with mixed liver diseases including liver tumors and other conditions in which iron overload may be present, which would substantially alter R2* and dominate any smaller but real relationship between fat content and R2*. The mechanism underlying the relationship between PDFF and R2* is not known. One plausible explanation is that fat droplets induce local susceptibility effects that accelerate the R2* decay of neighboring water molecules. It is known that fat and water have different magnetic dipole moments and therefore fat droplets 37 may act as small bar magnets and introduce focal magnetic field heterogeneities that accelerate R2* decay. The alternative explanation that fat has shorter R2* than water is unlikely to be true; recent studies by Horng et al and Hamilton et al 18, 38 have shown that the R2* of fat and water are essentially identical in human liver. Iron accumulation is unlikely to explain the relationship between PDFF and R2*, as it is rarely found histologically in children with NAFLD, especially those in which conditions associated with iron overload were excluded clinically. Moreover, the observed ranges of R2* at 3T are not suggestive of meaningful iron overload. 7, 39 Our study cannot exclude the possibility that the relationship is mediated by histological factors other than iron, as histology was not available. Further study is needed to examine the postulated role of fat-droplet-induced susceptibility as well as explore other possible mechanisms.
The reason for slight overestimation in R2* by MRI-M relative to MRI-C is unclear. Hernando et al 17 showed
in simulations that, due to noise-floor effects, magnitudebased reconstructions underestimate R2* compared to complex-based reconstructions, particularly at high R2* values. Since our patients tended to have low R2* values, noise-floor effects should be negligible. Further research is needed to confirm and explain the discrepancy in R2* estimation by MRI-M and MRI-C in the low R2* range. The slight underestimation of PDFF by MRI-M is consistent with previous studies. 24, 25 Although the PDFF signal model implicitly assumes that PDFF and R2* reflect distinct and unrelated physiological processes, our study suggests that the two measurements may not be completely distinct and may be interdependent. Regardless of the mechanism underlying the relationship, our study suggests that PDFF be considered in the interpretation of mild elevations in R2*. We speculate, for example, that in the setting of low PDFF, mild R2* elevation indicates iron overload; in the setting of high PDFF, however, mild R2* elevation is nonspecific and could reflect iron overload or the effects of fat accumulation on R2*, or both. Further research is needed to understand whether and how to modify the interpretation of hepatic R2* based on contemporaneous hepatic PDFF.
The close agreement in PDFF and R2* estimated by the two techniques suggests that either technique is likely to be suitable for clinical care and for clinical trials. Both techniques were used in this study because the close agreement for R2* estimation had not been verified previously, and so it was previously unknown whether the PDFF-R2* relationship was technique-dependent. Despite the close agreement in PDFF and R2* estimations, there were small but statistically significant differences. Thus, caution is suggested in applying these techniques interchangeably for estimation of PDFF and R2* clinically.
The lack of histology was a meaningful limitation of our study, as it precluded an analysis of possible histologic determinants that may explain the PDFF-R2* relationship. Future studies should include histology to explore possible underlying mechanisms. This was a single-site study performed on a single scanner at one field strength, and further validation is required.
In conclusion, our study suggests that in children with a wide range of hepatic PDFF and who were unlikely to have iron overload, there is a direct correlation between PDFF and R2*, and this relationship is observed in estimations using two independent MRI techniques. Our findings suggest that the PDFF value should be considered when interpreting the R2* value in human liver. Further research in children and adults is needed to independently verify our results and to understand the underlying mechanism.
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